What are the indications for tizanidine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tizanidine Indications

Tizanidine is FDA-approved for the management of spasticity (increased muscle tone), with treatment reserved for daily activities and times when relief of spasticity is most important. 1

FDA-Approved Indication

  • Tizanidine is indicated as a short-acting drug for managing spasticity, specifically for upper motor neuron syndromes including stroke, multiple sclerosis, and spinal cord injury. 1, 2
  • The medication should be reserved for those daily activities and times when relief of spasticity is most important due to its short duration of effect. 1

Specific Clinical Scenarios for Use

Spasticity-Related Complications

  • Tizanidine is recommended for chronic stroke patients with spasticity resulting in pain, poor skin hygiene, or decreased function. 3, 4
  • The American Heart Association specifically endorses tizanidine for these indications in chronic stroke patients, with maintained antispastic efficacy over time. 5

Multiple Sclerosis

  • Tizanidine produces a 20% mean reduction in muscle tone in MS patients, with approximately 75% reporting subjective improvement without increased muscle weakness. 6
  • The medication achieves maximum effect on spasticity within 1 week of starting treatment, with benefit maintained for at least 1 week after discontinuation. 6

Spinal Cord Injury

  • Tizanidine significantly reduces muscle tone (assessed by Ashworth score) in patients with spinal cord injury of >12 months' duration, without significant alterations in muscle strength. 7

Off-Label Use (Not FDA-Approved)

Acute Low Back Pain

  • The American College of Physicians recognizes tizanidine as an option for short-term relief of acute low back pain, though this is not an FDA-approved indication. 4, 5
  • When used for low back pain, treatment duration in clinical trials was typically 2 weeks or less. 4
  • Combining tizanidine with paracetamol provides superior short-term pain relief in patients with acute muscle spasms and back pain, though this increases the risk of CNS side effects (sedation and dizziness). 5

Critical Contraindications and Inappropriate Uses

Hypotonia (Reduced Muscle Tone)

  • Tizanidine is specifically contraindicated for hypotonia—it treats increased muscle tone (spasticity), not reduced muscle tone. 2, 4
  • Using tizanidine in hypotonia would worsen the underlying condition by further reducing muscle tone. 2

Stroke Recovery Period

  • Unlike diazepam or other benzodiazepines, tizanidine is not contraindicated during stroke recovery. 4
  • Diazepam and benzodiazepines should be avoided during stroke recovery due to possible deleterious effects on recovery, in addition to sedation side effects. 3

Stepwise Treatment Algorithm

  • Tizanidine represents a second-line intervention after conservative measures (positioning, passive stretching, range of motion exercises) have been attempted. 3
  • For patients who do not respond to oral medications like tizanidine, more invasive options should be considered: botulinum toxin injections, phenol/alcohol blocks, intrathecal baclofen, or neurosurgical procedures (selective dorsal rhizotomy or dorsal root entry zone lesion). 3, 4

Common Pitfall to Avoid

  • Do not confuse spasticity (velocity-dependent hyperactivity of tonic stretch reflexes) with general muscle weakness or hypotonia—tizanidine will only benefit the former and may harm the latter. 3, 2

References

Guideline

Tizanidine for Hypotonia (Reduced Muscle Tone)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tizanidine for Spasticity Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Combining Tizanidine with Paracetamol for Muscle Spasms and Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.